Cart
sales@molnova.com
Denosumab
CAS No. 615258-40-7
Denosumab( —— )
Catalog No. M22148 CAS No. 615258-40-7
Denosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 510 | In Stock |
|
| 10MG | 736 | In Stock |
|
| 25MG | 1131 | In Stock |
|
| 50MG | 1479 | In Stock |
|
| 100MG | 2018 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDenosumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionDenosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
-
DescriptionDenosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number615258-40-7
-
Formula Weight147 kDa
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kuritani M, et al. Anti-mouse RANKL Antibodies Inhibit Alveolar Bone Destruction in Periodontitis Model Mice. Biol Pharm Bull.2018;41(4):637-643.
molnova catalog
related products
-
Nesiritide
Nesiritide is the recombinant form of the 32 amino acid human B-type natriuretic peptide, which is normally produced by the ventricular myocardium. It is an agonist of natriuretic peptide receptors (NPRs), with Kd values of 7.3 and 13 pM for NPR-A and NPR-C, respectively.
-
SKI II
SKI II is a highly selective and non-ATP-competitive S1P receptor inhibitor (IC50: 0.5 μM) while exhibiting no inhibitory action on other kinases including PKCα, PI3K, and ERK2.
-
Isosalipurposide
Isosalipurposide, a chalcone compound, exerts a cytoprotective effect against oxidative injury via Nrf2 activation.
